Ron Finklestien
Mark Zuckerberg sold $428M worth of Meta stock at the end of 2023
Mark Zuckerberg’s Stock Sale Shakes Investors Drew Angerer 2023 proved to be a remarkable year for Meta Platforms (NASDAQ:META), emerging as the top-performing stock ...
CRISPR Therapeutics: A Glimpse into Future Therapies
CRISPR Therapeutics: A Glimpse into Future Therapies
Investing in the Future The field of gene therapies and gene editing technology holds immense promise for the future. CRISPR Therapeutics (NASDAQ:CRSP) has been ...
Investor’s Digest: Earnings Report on Walgreens, Conagra Brands, and More
Walgreens, Conagra Brands And 3 Stocks To Watch Heading Into Thursday
U.S. Stock Futures on the Rise As U.S. stock futures surged higher on Thursday morning, market participants have honed in on several key stocks ...
The Investment Landscape: A New Perspective
The Investment Landscape: A New Perspective
As you go through life, there are thousands of little forks in the road, and there are a few really big forks – those ...
TikTok sets sights on Amazon with goal of growing e-commerce tenfold
TikTok’s Ambitious E-Commerce Expansion TikTok Sets Sights on Amazon Sean Gallup/Getty Images News ByteDance’s (BDNCE) TikTok is aiming to 10x the merchandise volume of ...
Uncertain Start to Rate Cuts Sways Asia-Pacific Stocks
Uncertain Start to Rate Cuts Sways Asia-Pacific Stocks
Nikada Investors in Asia-Pacific markets faced a tumultuous day as U.S. Fed minutes delivered a disquieting signal about the initiation of rate cuts. The ...
After An 11% Fall Last Year Is Humana A Better Pick Over UnitedHealth Stock?
Humana’s Attractive Valuation Indicates a Superior Pick Over UnitedHealth Group Stock The Battle of Titans: Humana vs. UnitedHealth Group Investing in stocks is akin ...
Amerigo Resources: Navigating Stormy Weather in 2024
Amerigo Resources: Navigating Stormy Weather in 2024
The Road Ahead for Amerigo Resources French cabling specialist Nexans (OTCPK:NXPRF) (OTCPK:NEXNY) is currently the largest position in my stock portfolio and I’ve been ...
Longboard Pharmaceuticals Faces Stock Decline
A Shaky Offering: Longboard Pharmaceuticals Inc. Falters with Public Offering Announcement
Longboard Pharmaceuticals Inc LBPH shares are trading lower by 11.3% to $22.26 Wednesday afternoon after the company announced that it commenced a $150 million ...
